Capricor Therapeutics Announces Positive Topline Results from Pivotal Phase 3 HOPE-3 Study of Deramiocel in Duchenne Muscular Dystrophy
| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 09/10/25 | Registration statement under Securities Act of 1933 |
|
 |
99 | |
| 08/11/25 | Quarterly report [Sections 13 or 15(d)] |
|
|
57 | |
| 08/11/25 | Current report |
|
|
8 | |
| 07/29/25 | Statement of Beneficial Ownership by Certain Investors |
|
4 | ||
| 07/11/25 | Current report |
|
|
6 | |
| 06/16/25 | Securities to be offered to employees in employee benefit plans |
|
29 | ||
| 05/27/25 | Current report |
|
|
4 | |
| 05/14/25 | Quarterly report [Sections 13 or 15(d)] |
|
|
52 | |
| 05/13/25 | Current report |
|
|
8 | |
| 04/30/25 | Statement of Beneficial Ownership by Certain Investors |
|
4 |